299.2500 0.00 (0.00%)
NSE Mar 20, 2026 15:56 PM
Volume: 515.0K
 

Business Line
The progress India has made in terms of building the capabilities and number of scientists work in its favour.Also, India has a much better regulatory record than how it was perceived about 7 and 8 years ago': Suven Pharma's Executive Chairman Vivek Sharma
Number of FII/FPI investors decreased from 206 to 171 in Dec 2025 qtr
More from Cohance Lifesciences Ltd.
Recommended